Sangamo’s ART-less Approach In HIV Painting A Nice Picture
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Company shows it’s possible to achieve functional control of HIV with SB-728T after stopping antiretroviral therapy. But the “Berlin”-inspired genetic approach still needs to generate more data before the firms feels it can start partnering talks in earnest.